•Outcomes of tofacitinib dose reduction in patients with ulcerative colitis in stable remission: a long-term follow-up of the randomized RIVETING trial
•Prevalence of dysphagia and eosinophilic esophagitis in patients with inflammatory bowel disease or type 2 inflammation: a cross-sectional multicenter screening study
•Dynamic precision therapy in chronic gastrointestinal diseases: A focus on gastroesophageal reflux disease and inflammatory bowel disease-A narrative review and conceptual perspective
•Fatty acid-binding protein 2 in inflammatory bowel disease: mechanistic insights and translational perspectives
•A Receptor-Mediated Endolysosomal Recycling Chimera Enables Catalytic TNF-alpha Degradation for Sustained Treatment of Mucosal Inflammation
